Neutralizing Monoclonal Antibodies Block Chikungunya Virus Entry and Release by Targeting an Epitope Critical to Viral Pathogenesis
JIN ET AL. 2016. CELL REPORTS 13(11): 2553-2564.
RESOURCES
Where research scientists come to find up to date resources on antibody discovery against challenging membrane protein targets.
Protective Capacity of the Human Anamnestic Antibody Response during Acute Dengue Virus Infection.
XU ET AL. 2016. J VIROL 90(24):11122-11131.
Rapid isolation of dengue-neutralizing antibodies from single cell-sorted human antigen-specific memory B-cell cultures
COX ET AL. 2016. MABS 8(1):129-140.
Structural basis for nonneutralizing antibody competition at antigenic site II of the respiratory syncytial virus fusion protein
MOUSA ET AL. 2016. PNAS 113(44), E6849–E6858.
Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice
SAPPARAPU ET AL. 2016. NATURE 540, 443–447.
Signal transmission through the CXC chemokine receptor 4 (CXCR4) transmembrane helices
WESCOTT ET AL. 2016. PNAS 113(35):9928-9933.
Human Antibodies that Recognize Novel Immunodominant Quaternary Epitopes on the HIV-1 Env Protein
HICAR ET AL. 2016. PLOS ONE 11(7):E0158861.
Dengue Virus prM-Specific Human Monoclonal Antibodies with Virus Replication-Enhancing Properties Recognize a Single Immunodominant Antigenic Site.
SMITH ET AL. 2016. JOURNAL OF VIROLOGY 90(2):780-789.
Discovery and Characterization of Phage Display-Derived Human Monoclonal Antibodies against RSV F Glycoprotein
CHEN ET AL. 2016. PLOS ONE 11(6): E0156798.
Antibody Treatment of Ebola and Sudan Virus Infection via a Uniquely Exposed Epitope within the Glycoprotein Receptor-Binding Site
HOWELL ET AL. 2016. CELL REPORTS 15(7):1514-26.
